Trial intelligence / Profile preview

HALT-IT trial of tranexamic acid for acute gastrointestinal bleeding

ISRCTN11225767Phase 3Completed

Sponsor
London School of Hygiene & Tropical Medicine
Start
Jan 2013
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in gastrointestinal bleeding comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Death from haemorrhage within 5 days of randomisation, All-cause mortality and 2 more. Started Jan 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

gastrointestinal bleeding

Beyond the preview

Go deeper on ISRCTN11225767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN11225767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call